Abraham Rubinstein
- Pharmaceutical Science top 0.1%
- Molecular Biology top 10%
- Biomaterials top 2%
- Organic Chemistry top 5%
- Food Science top 2%
- Co-authors
- Morris SrebnikReem SmoumYechezkel BarenholzBoaz TiroshIrit Gliko-KabirAviram NissanValery M. DembitskyAmnon Sintov
- Topics
- Drug Solubulity and Delivery Systems (18 papers)Advanced Drug Delivery Systems (17 papers)Nanoparticle-Based Drug Delivery (10 papers)
- Partner nations
- IsraelUnited StatesRussia
In The Last Decade
Abraham Rubinstein
112 papers receiving 4.2k citations
Peers
Comparison fields: 5 of 143
- Pharmaceutical Science 1.3k
- Molecular Biology 1.0k
- Biomaterials 687
- Organic Chemistry 646
- Food Science 521
Countries citing papers authored by Abraham Rubinstein
This map shows the geographic impact of Abraham Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abraham Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abraham Rubinstein more than expected).
Fields of papers citing papers by Abraham Rubinstein
This network shows the impact of papers produced by Abraham Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abraham Rubinstein. The network helps show where Abraham Rubinstein may publish in the future.
Co-authorship network of co-authors of Abraham Rubinstein
This figure shows the co-authorship network connecting the top 25 collaborators of Abraham Rubinstein. A scholar is included among the top collaborators of Abraham Rubinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abraham Rubinstein. Abraham Rubinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 15 | |
| 3 | 7 | |
| 4 | 92 | |
| 5 | 15 | |
| 6 | 5 | |
| 7 | 139 | |
| 8 | 90 | |
| 9 | 4 | |
| 10 | 112 | |
| 11 | 15 | |
| 12 | 83 | |
| 13 | 3 | |
| 14 | SYNTHESIS AND SWELLING DEPENDENT ENZYMATIC DEGRADATION OF BORAX MODIFIED GUAR GUM FOR COLONIC DELIVERY PURPOSES | 34 |
| 15 | 63 | |
| 16 | 51 | |
| 17 | 10 | |
| 18 | 6 | |
| 19 | 5 | |
| 20 | Promethazine immunosuppression of Rh erythroblastosis | 1 |
About Abraham Rubinstein
Abraham Rubinstein is a scholar working on Pharmaceutical Science, Molecular Medicine and Nutrition and Dietetics, having authored 113 papers that have together received 4.4k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (18 papers), Advanced Drug Delivery Systems (17 papers) and Nanoparticle-Based Drug Delivery (10 papers). The work is most often cited by research in Pharmaceutical Science (1.3k citations), Molecular Medicine (392 citations) and Gastroenterology (342 citations). Abraham Rubinstein has collaborated with scholars based in Israel, United States and Russia. Frequent co-authors include Morris Srebnik, Reem Smoum, Yechezkel Barenholz, Boaz Tirosh, Irit Gliko-Kabir, Aviram Nissan, Valery M. Dembitsky, Amnon Sintov, Boris Yagen and Adel Penhasi. Their work appears in journals such as Chemical Reviews, Journal of Biological Chemistry and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.